INVESTOR CENTER

Flora Growth is a global cannabis company that leverages all-natural, low-cost cultivation practices to supply cannabis derivatives to its diverse business divisions of pharmaceuticals, cosmetics, hemp textiles, and food and beverage.

Capital Structure

Shares Outstanding

42.0 M​

Options​ & Warrants

12.4 M​

Fully-Diluted Shares Outstanding

54.4 M

Press Releases

FLORA GROWTH EXECUTES INTERNATIONAL SALES AGREEMENT TO ENTER AUSTRALIAN MEDICAL CANNABIS AND OVER-THE-COUNTER CBD MARKET

• Flora signs Letter of Intent with an international distributor based in Australia to provide raw and finished medical cannabis products for medical cannabis patients

• Recent Colombian legislative update allows for the sale and export of raw cannabis materials, namely dried flower, in addition to derivatives, to international markets

• Australian medical cannabis market estimated to surpass AU$200 million in 2021 and US$1.5 billion by 2025, with patient numbers growing exponentially in recent years

• Estimates predict the pharmacist-only CBD market in Australia itself will grow to AU$250 million in product sales at market maturity, capturing ~2M consumers

• Australian authorities recently down-scheduled cannabidiol (“CBD”) from Schedule 4 to Schedule 3, allowing the opportunity for consumers to purchase CBD products over-the-counter

Read More »

FLORA GROWTH TO PARTNER WITH AVARIA TO DISTRIBUTE AWARD-WINNING PAIN CREAM BRAND KALAYA ACROSS LATAM & PRODUCE ITS CBD FORMULATIONS

• Flora Growth has signed a Letter of Intent with Avaria Inc. to form a joint venture for the sale of its award-winning KaLaya brand across LATAM, including Flora Labs’ 2,500+ Colombian distribution channels.

• KaLaya has sold over a million units and is currently distributed via major retailers including Loblaws, Walmart, and London drugs across Canada, holding the number one customer retention rate in Loblaws’ pain cream categories.

• Flora will support the development and production of CBD pain cream formulations for the global market, with an immediate focus on LATAM and import into the United States.

Read More »

FLORA GROWTH APPLAUDS UPDATE TO COLOMBIAN CANNABIS REGULATIONS THAT SUBSTANTIALLY INCREASES REVENUE POTENTIAL; EXECUTES INTERNATIONAL CANNABIS SUPPLY AGREEMENT

• Colombian legislative update now allows for the sale and export of raw cannabis materials, namely dried flower, to international markets

• New regulations position Colombia’s cultivators as leaders to supply the global cannabis market; dried cannabis flower continues to account for an estimated 50% of demand in major international markets, including US, Germany, and Australia (1)

• New regulations allow for the manufacturing, sale, and export of ingestible cannabinoid products in Colombia, increasing near term revenue potential for Flora’s Kasa Wholefoods division

• Flora capitalizes on law change, signing a supply agreement with an international distributor based in South Africa to provide raw and finished medical cannabis products

• Update allows for the promotion and advertising of cannabis brands and products in Colombia, increasing access to the growing Colombian cannabis market

Read More »